Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc.

Overview
Date Founded

1978

Headquarters

1125 TRENTON-HARBOURTON ROAD, PO BOX 200, TITUSVILLE, NJ, 08560, USA

Type of Company

Private

Employees (Worldwide)

1,600

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries

Company Description

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Contact Data
Trying to get in touch with decision makers at Janssen Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President

General Counsel

Clinical Leader

Senior Director

Corporate Communications Executive

Customer Director

Regional Business Director

Medical Director

Director Client Services

Director

Board of Directors

President at Society For Neuroscience

Paths to Janssen Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Janssen Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Johnson & Johnson, Janssen Pharmaceuticals, Inc. purchase XO1 Ltd. from Total Medical Ventures, Index Ventures SA

Transaction Advisors
Legal Advisor

Advised onJohnson & Johnson, Janssen Pharmaceuticals, Inc. purchase XO1 Ltd. from Total Medical Ventures, Index Ventures SA

Advisors & Consultants
Legal Advisor

US Chair, Life Sciences Patent Litigation Practice at DLA Piper

Consultant

Chairman & Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at University of Texas - MD Anderson Cancer Center

Legal Advisor

Partner at Tucker Ellis LLP

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$601M
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Janssen Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Janssen Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Janssen Pharmaceuticals, Inc..